News
- December 11, 2009
- Technologie Biolactis Inc. announces the filing of a new patent protecting a major discovery with respect to the modulation of the obesity related metabolic pathway: Method of regulating PPAR, obesity related pathway and their associated metabolic impact.
- December 1, 2009
- BiolActis reports positive metabolic syndrome clinical trial data at major international meetings and events
- September 16, 2009
- Responsable (AQ - CQ) / Réglementation
- June 4, 2009
- Employment Opportunity
- April 20, 2009
- Technologie BiolActis Inc. reports its randomized and double-blinded clinical trial results for MPM-SL0905
- January 16, 2008
- Technologie Biolactis announces the filing of a new Patent protecting a major discovery with respect to the modulation of the Immune System: "Method for regulating TH17 Pathway".
- June 4, 2007
- Technologie Biolactis received the 2007 “Promising Early Stage Company” award from BIOTECanada.
- February 9, 2006
- Wall Street Reporter interview with Pierre Lemieux CEO of Biolactis
- February 7, 2006
- $10 million funding for Biolactis